MedPath

PARACRINE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)

ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma

Phase 3
Not yet recruiting
Conditions
Scleroderma, Diffuse
First Posted Date
2021-12-08
Last Posted Date
2022-09-28
Lead Sponsor
Paracrine, INC.
Target Recruit Count
174
Registration Number
NCT05148598

Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot Ulcers

Phase 3
Not yet recruiting
Conditions
Diabetic Foot Ulcer
First Posted Date
2021-10-27
Last Posted Date
2022-09-28
Lead Sponsor
Paracrine, INC.
Target Recruit Count
290
Registration Number
NCT05095389

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.